Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Journal Article


Authors: Edwards, B. K.; Ward, E.; Kohler, B. A.; Eheman, C.; Zauber, A. G.; Anderson, R. N.; Jemal, A.; Schymura, M. J.; Lansdorp-Vogelaar, I.; Seeff, L. C.; Van Ballegooijen, M.; Goede, S. L.; Ries, L. A. G.
Article Title: Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
Abstract: BACKGROUND. The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updated information regarding cancer occurrence and trends in the United States. This year's report includes trends in colorectal cancer (CRC) incidence and death rates and highlights the use of microsimulation modeling as a tool for interpreting past trends and projecting future trends to assist in cancer control planning and policy decisions. METHODS. Information regarding invasive cancers was obtained from the NCI, CDC, and NAACCR; and information on deaths was obtained from the CDC's National Center for Health Statistics. Annual percentage changes in the age-standardized incidence and death rates (based on the year 2000 US population standard) for all cancers combined and for the top 15 cancers were estimated by joinpoint analysis of long-term trends (1975-2006) and for short-term fixed-interval trends (1997-2006). All statistical tests were 2-sided. RESULTS. Both incidence and death rates from all cancers combined significantly declined (P < .05) in the most recent time period for men and women overall and for most racial and ethnic populations. These decreases were driven largely by declines in both incidence and death rates for the 3 most common cancers in men (ie, lung and prostate cancers and CRC) and for 2 of the 3 leading cancers in women (ie, breast cancer and CRC). The long-term trends for lung cancer mortality in women had smaller and smaller increases until 2003, when there was a change to a nonsignificant decline. Microsimulation modeling demonstrates that declines in CRC death rates are consistent with a relatively large contribution from screening and with a smaller but demonstrable impact of risk factor reductions and improved treatments. These declines are projected to continue if risk factor modification, screening, and treatment remain at current rates, but they could be accelerated further with favorable trends in risk factors and higher utilization of screening and optimal treatment. CONCLUSIONS. Although the decrease in overall cancer incidence and death rates is encouraging, rising incidence and mortality for some cancers are of concern. © 2009 American Cancer Society.
Keywords: adult; aged; middle aged; major clinical study; mortality; bevacizumab; fluorouracil; cancer risk; note; united states; cancer incidence; neoplasms; colorectal cancer; breast cancer; incidence; risk factors; cancer screening; lung cancer; cetuximab; risk factor; cancer mortality; time factors; irinotecan; prostate cancer; colorectal neoplasms; cancer invasion; registries; early diagnosis; cancer registry; computer simulation; sex difference; cancer epidemiology; cancer control; epidemiology; oxaliplatin; risk reduction; trend study; race difference; health care planning; surveillance; end results; cancer intervention and surveillance modeling network colon models; microsimulation models; national program of cancer registries; north american association of central cancer registries
Journal Title: Cancer
Volume: 116
Issue: 3
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2010-02-01
Start Page: 544
End Page: 573
Language: English
DOI: 10.1002/cncr.24760
PUBMED: 19998273
PROVIDER: scopus
PMCID: PMC3619726
DOI/URL:
Notes: --- - "Cited By (since 1996): 60" - "Export Date: 20 April 2011" - "CODEN: CANCA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ann G Zauber
    314 Zauber